UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

The American heart journal, 2010-11, Vol.160 (5), p.928-933

2010

Link zum Volltext

Verfügbarkeit prüfen

Association Between Bilirubin and Mode of Death in Severe Systolic Heart Failure

The American journal of cardiology, 2013-04, Vol.111 (8), p.1192-1197

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

The New England journal of medicine, 1996-10, Vol.335 (15), p.1107-1114

1996

Link zum Volltext

Verfügbarkeit prüfen

In COVID-19 Patients Who Suffer In-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation Outcomes May Be Impacted by Arrest Etiology and Local Pandemic Conditions

Critical care explorations, 2022-02, Vol.4 (2), p.e0605-e0605

2022

Link zum Volltext

Verfügbarkeit prüfen

The cost of end-of-life care: a new efficiency measure falls short of AHA/ACC standards

Circulation Cardiovascular quality and outcomes, 2009-03, Vol.2 (2), p.127-133

Neuberg, Gerald W

2009

Link zum Volltext

Verfügbarkeit prüfen

Diuretic resistance predicts mortality in patients with advanced heart failure

The American heart journal, 2002-07, Vol.144 (1), p.31-38

2002

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure

Circulation (New York, N.Y.), 1995-09, Vol.92 (6), p.1499-1506

1995

Link zum Volltext

Verfügbarkeit prüfen

Internet-enabled thyroid hormone abuse

Annals of internal medicine, 2009-01, Vol.150 (1), p.60

2009

Link zum Volltext

Verfügbarkeit prüfen

Circadian rhythm and sudden death in heart failure

Journal of the American College of Cardiology, 2000-08, Vol.36 (2), p.541-546

2000

Link zum Volltext

Verfügbarkeit prüfen

Circadian rhythm and Sudden death in heart failure: Results from Prospective Randomized Amlodipine Survival Trial

Journal of the American College of Cardiology, 2000-08, Vol.36 (2), p.541-546

2000

Link zum Volltext

Verfügbarkeit prüfen

Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trial

The American journal of cardiology, 1998-10, Vol.82 (7), p.881-887

1998

Link zum Volltext

Verfügbarkeit prüfen

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor ? Results of the flosequinan-ACE inhibitor trial (FACET)

Circulation (New York, N.Y.), 1993-08, Vol.88 (2), p.492-501

1993

Link zum Volltext

Verfügbarkeit prüfen

Effect of digoxin withdrawal in patients with chronic heart failure receiving carvedilol

Journal of cardiac failure, 2004-08, Vol.10 (4), p.S87-S87

2004

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure

The American journal of cardiology, 1991, Vol.67 (1), p.63-66

1991

Link zum Volltext

Verfügbarkeit prüfen

Cardiopulmonary exercise testing. The clinical value of gas exchange data

Archives of internal medicine (1960), 1988-10, Vol.148 (10), p.2221

1988

Link zum Volltext

Verfügbarkeit prüfen

Cardiopulmonary Exercise Testing An Idea Whose Time Has Almost Come

Chest, 1990-02, Vol.97 (2), p.257-258

Neuberg, Gerald W.

1990

Link zum Volltext

Verfügbarkeit prüfen

High diuretic doses are associated with sudden death in patients with advanced heart failure: The PRAISE trial

Journal of cardiac failure, 1998-09, Vol.4 (3), p.34-34

1998

Link zum Volltext

Verfügbarkeit prüfen

Lymphocyte G proteins reflect response to treatment in congestive heart failure

The American heart journal, 1995, Vol.129 (1), p.98-106

1995

Link zum Volltext

Verfügbarkeit prüfen

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Medicine and science in sports and exercise, 1989-04, Vol.21 (Supplement), p.S11

1989

Link zum Volltext

Verfügbarkeit prüfen

Renin inhibition (but not plasma renin activity) predicts the response to converting-enzyme inhibitors in chronic heart failure

Journal of the American College of Cardiology, 1990-02, Vol.15 (2), p.A172-A172

1990

Link zum Volltext

Verfügbarkeit prüfen

Can acute hemodynamic studies in heart failure be used to predict the optimal dose of a new drug during long-term therapy?

Journal of the American College of Cardiology, 1991-02, Vol.17 (2), p.A163-A163

1991

Link zum Volltext

Verfügbarkeit prüfen

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Medicine and science in sports and exercise, 1980-04, Vol.21 (Supplement), p.S11

1980

Link zum Volltext

Verfügbarkeit prüfen

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Medicine and science in sports and exercise, 1989-04, Vol.21 (2 Suppl), p.S11-S11

1989

Link zum Volltext

Verfügbarkeit prüfen

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Medicine and science in sports and exercise, 1980-04, Vol.21 (2 Suppl), p.S11-S11

1980

Link zum Volltext

Verfügbarkeit prüfen

Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations

Pediatric blood & cancer, 2015-10, Vol.62 (10), p.1855-1858

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure

Association Between Bilirubin and Mode of Death in Severe Systolic Heart Failure

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

In COVID-19 Patients Who Suffer In-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation Outcomes May Be Impacted by Arrest Etiology and Local Pandemic Conditions

The cost of end-of-life care: a new efficiency measure falls short of AHA/ACC standards

Diuretic resistance predicts mortality in patients with advanced heart failure

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure

Internet-enabled thyroid hormone abuse

Circadian rhythm and sudden death in heart failure

Circadian rhythm and Sudden death in heart failure: Results from Prospective Randomized Amlodipine Survival Trial

Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trial

Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor ? Results of the flosequinan-ACE inhibitor trial (FACET)

Effect of digoxin withdrawal in patients with chronic heart failure receiving carvedilol

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure

Cardiopulmonary exercise testing. The clinical value of gas exchange data

Cardiopulmonary Exercise Testing An Idea Whose Time Has Almost Come

High diuretic doses are associated with sudden death in patients with advanced heart failure: The PRAISE trial

Lymphocyte G proteins reflect response to treatment in congestive heart failure

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Renin inhibition (but not plasma renin activity) predicts the response to converting-enzyme inhibitors in chronic heart failure

Can acute hemodynamic studies in heart failure be used to predict the optimal dose of a new drug during long-term therapy?

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

ENDURANCE TRAINING AUGMENTS THE RISE IN PLASMA ATRIAL NATRIURETIC FACTOR DURING EXERCISE IN MAN: 66

Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations

Suchergebnisse filtern